Barriers and facilitators to substance use disorder treatment: An overview of systematic reviews

A Farhoudian, E Razaghi, Z Hooshyari… - Substance abuse …, 2022‏ - journals.sagepub.com
objective: This investigation explored the barriers and facilitators to substance use disorder
(SUD) treatment in the integrated paradigm. methods: A search technique for barriers and …

The opioid crisis: the war on drugs is over. Long live the war on drugs

M Gottschalk - Annual review of criminology, 2023‏ - annualreviews.org
A closer examination of media coverage, the response of law enforcement and policy
makers, the legislative record, and the availability of proven, high-quality treatments for …

Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder

EA Evans, D Wilson, PD Friedmann - Drug and alcohol dependence, 2022‏ - Elsevier
Background Buprenorphine is an effective medication for opioid use disorder (MOUD) when
offered in community-based settings, but evidence is limited for incarcerated populations …

The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review

N Kumar, W Oles, BA Howell, K Janmohamed… - Journal of Substance …, 2021‏ - Elsevier
Background Social connections can lead to contagion of healthy behaviors. Successful
treatment of patients with opioid use disorder may lay in rebuilding social networks. Strong …

Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted …

CK Scott, CE Grella, ML Dennis, J Carnevale… - Health & justice, 2022‏ - Springer
Background Jails are optimal settings in which to screen individuals for opioid use disorders
(OUD) and provide needed services, especially medications for OUD (MOUD). This study …

Availability of medications for the treatment of opioid use disorder among pregnant and postpartum individuals in US jails

C Sufrin, CT Kramer, M Terplan, K Fiscella… - JAMA network …, 2022‏ - jamanetwork.com
Importance Thousands of pregnant people with opioid use disorder (OUD) enter US jails
annually, yet their access to medications for OUD (MOUD) that meet the standard of care …

Medication for opioid use disorder treatment continuity post-release from jail: a qualitative study with community-based treatment providers

TJ Stopka, RE Rottapel, WJ Ferguson… - International Journal of …, 2022‏ - Elsevier
Background People released from jail are at elevated opioid overdose risk. Medications for
opioid use disorder (MOUD) are effective in reducing overdoses. MOUD treatment was …

[HTML][HTML] Disparities in Medication Use for Criminal Justice System–Referred Opioid Use Disorder Treatment

JT Donahoe, JM Donohue, BK Saloner - JAMA Health Forum, 2024‏ - jamanetwork.com
Importance Individuals with opioid use disorder (OUD) and criminal justice system
involvement experience high rates of overdose death. Historical data point to limited use of …

Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in …

A Matsumoto, C Santelices, EA Evans… - International Journal of …, 2022‏ - Elsevier
Background Individuals with opioid use disorder released to communities after incarceration
experience an elevated risk for overdose death. Massachusetts is the first state to mandate …

Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review

C Russell, TP George, N Chopra, B Le Foll… - The American Journal …, 2024‏ - Taylor & Francis
Background: Medications for opioid use disorder (MOUD) reduce risks for overdose among
correctional populations. Among other barriers, daily dosing requirements hinder treatment …